CSBR — Champions Oncology Share News
0.000.00%
Last trade - 00:00- $66.67m
- $63.16m
- $59.43m
Brief: Champions Oncology Reports Q1 Revenue Rose 23.7 Pct To $6.2 Mln
Brief: Champions Oncology QTRLY Loss Per Share GAAP $0.06
Clinical Pdx Studies
Brief: Champions Oncology Reports Quarterly Revenue Of $5.1 Million
Brief: Champions Oncology Reports Record Quarterly Revenue Of $5.2 Million
Brief: Champions Biotechnology reports Q1 loss per share $0.06
Brief: Champions Oncology announces strategic collaboration with AstraZeneca to develop unique cohorts of PDX models
Brief: Champions Oncology to collaborate with Addario Lung Cancer Medical Institute
Brief: Champions Oncology posts Q3 adj. loss per share $0.11
Brief: Champions Biotechnology Inc says announces plan to open new lab facility in Rockville, Maryland
Brief: Champions biotechnology announced addition of new cohorts of PDX models to existing Tumorbank
Brief: Norman Pessin reports 5.2 pct stake in Champions Oncology
Brief: Champions Oncology says Q2 revenue rose 50 pct to $4.5 mln
Brief: Champions Oncology reports Q1 GAAP loss per share $ 0.26
Brief: Champions Oncology announces pricing of public offering of common stock
Brief: Champions Oncology Q3 Non-GAAP loss per share $0.21